CTRI/2019/05/019125
Completed
未知
Prevalence of sepsis in critically ill patients in India: A single-day, prospective, observational, multicentre, nation-wide point-prevalence study - SIPS
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The George Institute for Global Health
- Enrollment
- 666
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All adult patients (18 years or older) present in the ICU at the start of the study day or admitted during the 24\-hour study period will be included in the study sample.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Pilot randomised controlled trial of continuous beta-lactam infusion compared with intermittent dosing in critically ill patientsACTRN12610000238077Beta-Lactam Infusion Group60
Not yet recruiting
Not Applicable
A prospective observational study to assess the Prevalence and Outcome of Sepsis-induced Cardiomyopathy in Intensive Care UnitsCTRI/2024/06/069149JNMCH Department of Anaesthesiology and Critical Care Jawaharlal Nehru Medical College AM
Recruiting
Phase 4
Optimising cefepime dosing in intensive care: the pharmacokinetics of extended (prolonged) infusions.ACTRN12609000069257The Alfred30
Not yet recruiting
Not Applicable
Occurence and outcome of sick patients with COVID 19 and new kidney disease.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2021/11/037973SMS medical college and hospital
Active, not recruiting
Phase 4
SepTIC: Sepsis Trials in Critical CareSepsisInfections and InfestationsISRCTN80791572Imperial College London3,758